Total Payments
$3,680
2023 Payments
$273.57
Companies
24
Transactions
213
Medicare Patients
779
Medicare Billing
$158,294
Payment Breakdown by Category
Food & Beverage$3,650 (99.2%)
Education$29.99 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,650 | 212 | 99.2% |
| Education | $29.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $434.49 | 25 | $0 (2023) |
| Allergan, Inc. | $424.24 | 25 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $369.02 | 19 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $361.93 | 21 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $356.00 | 21 | $0 (2023) |
| Shire North American Group Inc | $278.53 | 19 | $0 (2019) |
| Lundbeck LLC | $225.64 | 13 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $178.13 | 9 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $140.62 | 8 | $0 (2023) |
| Neos Therapeutics, LP | $131.22 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $273.57 | 15 | ABBVIE INC. ($95.25) |
| 2022 | $489.66 | 26 | ABBVIE INC. ($175.09) |
| 2021 | $487.87 | 30 | AbbVie Inc. ($164.15) |
| 2020 | $350.21 | 21 | Takeda Pharmaceuticals U.S.A., Inc. ($122.32) |
| 2019 | $328.21 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($45.51) |
| 2018 | $654.40 | 40 | Allergan Inc. ($161.25) |
| 2017 | $1,096 | 63 | Allergan Inc. ($209.69) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Neuropsychiatry | ||||||
| 06/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Central Nervous System | ||||||
| 05/08/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Neuropsychiatry | ||||||
| 04/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/28/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Central Nervous System | ||||||
| 03/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: PSYCHIATRY | ||||||
| 01/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Central Nervous System | ||||||
| 12/12/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Central Nervous System | ||||||
| 11/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Neuroscience | ||||||
| 09/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 154 | 474 | $115,931 | $36,751 |
| 2022 | 4 | 187 | 518 | $108,245 | $40,063 |
| 2021 | 7 | 217 | 552 | $103,355 | $43,488 |
| 2020 | 5 | 221 | 593 | $105,811 | $37,992 |
Total Patients
779
Total Services
2,137
Medicare Billing
$158,294
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 275 | $77,409 | $25,052 | 32.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 51 | 153 | $25,857 | $7,786 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 19 | $7,307 | $2,383 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 27 | $5,358 | $1,529 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 295 | $68,815 | $26,547 | 38.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 60 | 166 | $26,102 | $8,500 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 26 | $8,298 | $3,332 | 40.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 31 | $5,030 | $1,684 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 247 | $53,105 | $23,970 | 45.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 54 | 174 | $26,622 | $8,968 | 33.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 25 | $7,200 | $3,704 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 39 | $5,733 | $2,373 | 41.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 28 | 36 | $5,508 | $2,189 | 39.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 18 | $3,978 | $1,732 | 43.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 13 | $1,209 | $552.48 | 45.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 251 | $53,965 | $18,571 | 34.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 55 | 172 | $26,316 | $9,185 | 34.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 81 | $11,907 | $4,295 | 36.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 20 | 46 | $7,751 | $3,652 | 47.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 30 | 43 | $5,872 | $2,289 | 39.0% |
About Dr. Cliff Lin, M.D
Dr. Cliff Lin, M.D is a Psychiatry healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689963282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cliff Lin, M.D has received a total of $3,680 in payments from pharmaceutical and medical device companies, with $273.57 received in 2023. These payments were reported across 213 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,650).
As a Medicare-enrolled provider, Lin has provided services to 779 Medicare beneficiaries, totaling 2,137 services with total Medicare billing of $158,294. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Marietta, GA
- Active Since 04/04/2011
- Last Updated 12/04/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1689963282
Products in Payments
- VRAYLAR (Drug) $858.73
- REXULTI (Drug) $399.27
- TRINTELLIX (Drug) $373.47
- AUSTEDO (Drug) $319.93
- Trintellix (Drug) $199.07
- LATUDA (Drug) $178.13
- MYDAYIS (Drug) $170.27
- INGREZZA (Drug) $140.62
- Adzenys XR-ODT (Drug) $131.22
- VYVANSE (Drug) $124.57
- CAPLYTA (Drug) $101.39
- Fanapt (Drug) $93.63
- Dayvigo (Drug) $93.15
- INVEGA SUSTENNA (Drug) $53.33
- AZSTARYS (Drug) $45.70
- BELSOMRA (Drug) $44.02
- Evekeo (Drug) $43.49
- ADHANSIA XR (Drug) $40.14
- ABILIFY MAINTENA (Drug) $36.58
- SPRAVATO (Drug) $35.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Marietta
Dr. Michael Banov, Md, MD
Psychiatry — Payments: $1.2M
Psychiatry $1.2M
Dr. Michael Unger, M.d, M.D
Psychiatry — Payments: $83,233
Psychiatry $83,233
Dr. Amy Holland, M.d, M.D
Psychiatry — Payments: $14,581
Psychiatry $14,581
Mohamedlatif Saiyad, Md, MD
Psychiatry — Payments: $4,783
Psychiatry $4,783
Catharine Wolfe, Md, MD
Psychiatry — Payments: $2,883
Psychiatry $2,883
Dr. Rohit Khanna, M.d, M.D
Psychiatry — Payments: $2,670
Psychiatry $2,670